Back to Search
EMILY CAMP, M.D.
M.D.
Internal Medicine Physician
NPI: 1568998201IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
54875(KY)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE
Class of 2017
Research & Publications (20)
Nanog regulates proliferation during early fish development.
PMID 19544407·Stem Cells·2009
7-preclinical
Breast cancer screening in women exposed in utero to diethylstilbestrol.
PMID 19361323·J Womens Health (Larchmt)·2009
8-other
Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells.
PMID 18790786·Mol Cancer Ther·2008
8-other
Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol.
PMID 18369304·J Low Genit Tract Dis·2008
4-observational
Management of bevacizumab-associated bowel perforation: a case series and review of the literature.
PMID 18024857·Ann Oncol·2008
6-review
The development and characterization of a human midgut carcinoid cell line.
PMID 17699847·Clin Cancer Res·2007
7-preclinical
Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.
PMID 17653802·Ann Surg Oncol·2007
7-preclinical
Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.
PMID 17311308·Cancer·2007
8-other
Catalytic asymmetric methallylation of ketones with an (H8-BINOLate)Ti-based catalyst.
PMID 16986913·Org Lett·2006
8-other
The role of nitric oxide in mediating tumour blood flow.
PMID 16981826·Expert Opin Ther Targets·2006
6-review
Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
PMID 16857785·Clin Cancer Res·2006
8-other
Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer.
PMID 16638876·Clin Cancer Res·2006
7-preclinical
Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.
PMID 16397214·Cancer Res·2006
8-other
Enhanced sensitivity to chemotherapy in esophageal cancer through inhibition of NF-kappaB.
PMID 16337965·J Surg Res·2006
8-other
Minimizing local recurrence after breast conserving therapy using intraoperative shaved margins to determine pathologic tumor clearance.
PMID 16310688·J Am Coll Surg·2005
8-other
Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
PMID 16140945·Cancer Res·2005
7-preclinical
RON, a tyrosine kinase receptor involved in tumor progression and metastasis.
PMID 15827676·Ann Surg Oncol·2005
6-review
Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy.
PMID 15754332·Cancer·2005
6-review
Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptor.
PMID 15671571·Clin Cancer Res·2005
6-review
FAP with concurrent duodenal adenomatous polyposis and carcinoid tumor.
PMID 15334634·J Surg Oncol·2004
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 213 N HURSTBOURNE PKWY
LOUISVILLE, KY 40222 - Phone
- (502) 327-5135
Quick Facts
- NPI
- 1568998201
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile